BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 35091010)

  • 1. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Hui J; Yuan R; Li P; Xin Q; Miao Y; Shen X; Xu F; Cong W
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Liu Q; Dong T; Xi M; Gou L; Bai Y; Hou L; Li M; Ou L; Miao F; Wei P
    Evid Based Complement Alternat Med; 2021; 2021():9413704. PubMed ID: 34335841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
    Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
    Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Chung VC; Qin Y; Huang Y; Tam WW; Kwong JS; Xie W; Tang JL
    Cochrane Database Syst Rev; 2015 May; (5):CD010237. PubMed ID: 25994229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.
    Yang Y; Li X; Chen G; Xian Y; Zhang H; Wu Y; Yang Y; Wu J; Wang C; He S; Wang Z; Wang Y; Wang Z; Liu H; Wang X; Zhang M; Zhang J; Li J; An T; Guan H; Li L; Shang M; Yao C; Han Y; Zhang B; Gao R; Peterson ED;
    JAMA; 2023 Oct; 330(16):1534-1545. PubMed ID: 37874574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis.
    Li L; Feng P; Zhou W; Luo B; Deng L; Gan D; Wu X; Zhu F; Zhou X
    Front Cardiovasc Med; 2024; 11():1229299. PubMed ID: 38414926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjunctive therapy of xuezhikang capsule for coronary heart disease: a systematic review and meta-analysis of randomized controlled trials].
    Wang Y; Chen ZH; Liu GH; Zhang F; Zhang Z; Guan XF; Luo ZB; Yang GL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1182-91. PubMed ID: 25509259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Tongxinluo Capsule as Adjunctive Treatment for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li P; Xin Q; Hui J; Yuan R; Wang Y; Miao Y; Lee SM; Leng SX; Cong W;
    Front Pharmacol; 2021; 12():742978. PubMed ID: 34707500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tongxinluo Capsule () for Cardiac Syndrome X: A Systematic Review and Meta-Analysis.
    Mao HM; Liu M; Qu H; Wang LQ; Shi DZ
    Chin J Integr Med; 2018 Apr; 24(4):296-303. PubMed ID: 28819776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris.
    Wu T; Harrison RA; Chen X; Ni J; Zhou L; Qiao J; Wang Q; Wei J; Xin D; Zheng J
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004474. PubMed ID: 17054205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
    Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
    BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis.
    Mei J; Xu H; Xu FQ; Ju JQ
    Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Exercise after Percutaneous Coronary Intervention on Cardiac Function and Cardiovascular Adverse Events in Patients with Coronary Heart Disease: Systematic Review and Meta-Analysis.
    Zhang H; Chang R
    J Sports Sci Med; 2019 Jun; 18(2):213-222. PubMed ID: 31191090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tongxinluo capsule in combination with conventional therapies for stable angina pectoris: A meta-analysis and systematic review.
    Feng R; Lin Q; Wei D; Li Y; Zhang R; Jiang K; Li Y; Xie L; Xia J; Zheng P; Ji X; Wang W; Qu X; Gao Q; Pan Y; Liu J
    Medicine (Baltimore); 2023 Oct; 102(41):e35405. PubMed ID: 37832041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.